Determining the degree to which the body’s cells respond effectively to insulin, in conjunction with circulating levels of triglycerides, is a valuable diagnostic tool. This assessment often involves using the fasting insulin level and the triglyceride concentration in a specific formula to estimate insulin sensitivity. A common calculation is the triglyceride-glucose index (TyG index), derived from the formula: ln [Fasting Triglycerides (mg/dL) x Fasting Glucose (mg/dL) / 2]. The resulting index provides an indirect measure; higher values typically suggest increased resistance.
The assessment’s importance stems from its ability to identify individuals at risk for metabolic syndrome, type 2 diabetes, and cardiovascular disease. Elevated triglycerides, frequently associated with resistance to insulin, can indicate impaired glucose metabolism and increased cardiovascular risk factors. Historically, the gold standard for measuring insulin sensitivity was the euglycemic-hyperinsulinemic clamp, a complex and time-consuming procedure. Formulas utilizing triglycerides and fasting glucose offer a simpler, more accessible, and cost-effective means of estimating resistance in clinical and research settings.
